Trend of antibiotics usage for acute pyelonephritis in Korea based on national health insurance data 2010-2014

Autor: Bongyoung Kim, Jieun Kim, Rangmi Myung, Myoung-jae Lee, Hyunjoo Pai
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
Databases
Factual
National Health Programs
Antibiotics
Resistance
Antimicrobial Stewardship
National health insurance
0302 clinical medicine
Medical microbiology
030212 general & internal medicine
Practice Patterns
Physicians'
Aged
80 and over
Pyelonephritis
Middle Aged
Anti-Bacterial Agents
Infectious Diseases
Acute Disease
Antibiotic consumption
Female
beta-Lactamase Inhibitors
Fluoroquinolones
Research Article
Adult
medicine.medical_specialty
Adolescent
medicine.drug_class
030106 microbiology
lcsh:Infectious and parasitic diseases
03 medical and health sciences
Insurance Claim Review
Young Adult
Internal medicine
Republic of Korea
medicine
Health insurance
Humans
Stewardship
lcsh:RC109-216
Medical prescription
Aged
Acute pyelonephritis
Korea
3rd generation cephalosporins
business.industry
Drug Utilization
Cephalosporins
Defined daily dose
Tropical medicine
Intraabdominal Infections
business
Zdroj: BMC Infectious Diseases
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-7 (2019)
ISSN: 1471-2334
Popis: Background The objective of this study is to describe the changes in prescribing practices of antibiotics to treat acute pyelonephritis (APN) in Korea. Methods The claim data base of the Health Insurance Review and Assessment Service in Korea was used to select patients with ICD-10 codes N10 (acute tubulo-interstitial nephritis) or N12 (tubulo-interstitial nephritis, not specified as acute nor chronic) as the primary discharge diagnosis during 2010–2014. Consumption of each class of antibiotics was converted to Defined Daily Dose (DDD)/event. Results Throughout the five-year period, the average antibiotic consumption were 11.3 DDD per inpatient event and 6.0 DDD per outpatient event. The annual average antibiotic consumption increased for inpatients (P = 0.002), but remained stable for outpatients (P = 0.066). The use of parenteral antibiotics increased for inpatients (P
Databáze: OpenAIRE
Externí odkaz: